本页面由Tiger Trade Technology Pte. Ltd.提供服务

Ventyx Biosciences, Inc.

14.00
0.0000
成交量:- -
成交额:7,625.72万
市值:10.05亿
市盈率:-9.34
高:14.00
开:14.00
低:14.00
收:14.00
52周最高:25.00
52周最低:0.7830
股本:7,175.01万
流通股本:5,355.59万
量比:- -
换手率:- -
股息:- -
股息率:- -
每股收益(TTM):-1.4991
每股收益(LYR):-1.9732
净资产收益率:-45.35%
总资产收益率:-28.47%
市净率:5.25
市盈率(LYR):-7.10

数据加载中...

2023/05/03

关联方拟减持公告

144 - Report of proposed sale of securities
2023/05/03

关联方拟减持公告

144 - Report of proposed sale of securities
2023/04/28

关联方拟减持公告

144 - Report of proposed sale of securities
2023/04/07

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2023/03/23

重要事件披露

8-K - Current report
2023/03/23

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/03/22

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2023/03/02

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/01/30

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2023/01/26

重要事件披露

8-K - Current report
2023/01/12

重要事件披露

8-K - Current report
2023/01/05

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/12/30

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/12/20

重要事件披露

8-K - Current report
2022/12/16

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/12/15

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/12/12

重要事件披露

8-K - Current report
2022/11/30

重要事件披露

8-K - Current report
2022/11/09

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership